This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 30 Dec 2013  |  Europe

    The Untapped Potential in Live Cell Imaging (Technical Insights)

    Improved cellular dynamics in disease diagnostic and drug discovery.

    The study covers provides an assessment of the marketed and pipeline products for the global human albumin market. Segmentation by application has been provided along with additional information such as clinical trial timelines and results, and historical and projected launch timelines. The marketed and pipeline products have been broadly segmented...

    $4,950.00
  2. 27 Dec 2013  |  Global

    Emerging Technologies in Infectious Diseases Diagnostics (Technical Insights)

    Infectious diseases diagnostics for the developing world

    This research service focuses on the emerging diagnostic technologies (for TB, HIV, HCV, HPV), the developmental initiatives, corporate developments by market leaders, and the role of international organizations within this market. It enlists end-user demands. The research service discusses the existing healthcare structure within the developing re...

    $4,950.00
  3. 26 Dec 2013  |  Global

    Technology Breakthroughs in Aesthetic Procedures (Technical Insights)

    Advancements in laser technology to significantly increase non-invasive aesthetic procedures.

    Aesthetic procedures though cost intensive in nature, has experienced increased growth over the past decade. Companies have and are coming up in this space with all-inclusive vacation cum procedure packages which are alluring patients to undergo such procedures.  Since such procedures are not covered by health insurance, price is the major selling...

    $4,950.00
  4. The study assesses marketed and investigational products and combination regimens for the global breast cancer therapeutics market. Segmentation by drug class is provided, along with supporting information, such as clinical trial timelines and results, historical and projected launch timelines, and epidemiology. Marketed and pipeline products are b...

    $4,950.00
  5. 03 Sep 2013  |  Global

    Innovations in Allergy Treatment and Monitoring (Technical Insights)

    Therapy and Monitoring Advances Help Achieve Long-term Relief from Allergy

    The global human plasma-derived therapeutics market is expected to experience a surge in demand due to an increase in the awareness of diseases and therapeutic options. The plasma-derived therapeutics market is segmented into albumin, immunoglobulins, coagulation factors, and other haemotologicals. The segments are discussed with supporting informa...

    $4,950.00
  6. This research service offers an assessment for marketed and pipeline products for the global ACS therapeutics market. Segmentation by drug class is provided along with additional supporting information such as clinical trial timelines and results, historical and projected launch timelines, and epidemiology. The marketed and pipeline products are br...

    $4,950.00